Is Big Pharma Really Like Hollywood? | GenomeWeb

Over at In the Pipeline, Derek Lowe makes an analogy, comparing the movie business to big pharma. The similarities, he writes, are that both incur most of their costs in R&D and marketing spending and blockbusters are hard to predict. The differences are that the barrier to entry is a lot higher for distributing new drugs and movies can make money longer than patented drugs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.